Brevan Howard Capital Management LP Arrowhead Pharmaceuticals, Inc. Transaction History
Brevan Howard Capital Management LP
- $14.2 Billion
- Q3 2024
A detailed history of Brevan Howard Capital Management LP transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 10,403 shares of ARWR stock, worth $204,210. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,403
Previous 24,489
57.52%
Holding current value
$204,210
Previous $636,000
68.4%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding ARWR
# of Institutions
294Shares Held
90.8MCall Options Held
155KPut Options Held
426K-
Black Rock Inc. New York, NY15.7MShares$308 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$240 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.89MShares$174 Million2.59% of portfolio
-
State Street Corp Boston, MA6.35MShares$125 Million0.01% of portfolio
-
Slate Path Capital LP New York, NY4.89MShares$95.9 Million1.49% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $2.08B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...